Charles River Associates announced its acquisition of bioStrategies Group, a Chicago-based consulting firm focused on developing commercial strategies for healthcare products and technologies. Under the terms of the transaction, which closed on November 29, CRA purchased substantially all of the assets of bioStrategies Group and retained the services of 17 employees, including Mike Kaestle and Chris Schneider, who have joined CRA’s Life Sciences Practice as vice presidents.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CRAI:
